期刊文献+

免疫清除性化疗结合自体外周血造血干细胞移植治疗重症系统性红斑狼疮 被引量:3

Immunoablative chemotherapy with autologous peripheral blood stem cell rescule in patients with severe systemic lupus erythematosus.
下载PDF
导出
摘要 目的 观察免疫清除性化疗结合自体外周血造血干细胞移植 (移植 )治疗重症系统性红斑狼疮 (SLE)的疗效及安全性。方法 重症SLE 4例 ,分别合并狼疮性肾炎、狼疮脑、狼疮心或股骨头坏死 ,干细胞的动员采用环磷酰胺加重组人粒细胞集落因子 (G CSF) ;预处理为回输前 3天每天应用环磷酰胺 5 0mg/kg +回输后 3天每天应用抗胸腺细胞球蛋白 (ATG) 5mg/kg。观察移植前后临床症状、体征、狼疮相关抗体等指标的改变 ,并动态观察移植后免疫功能的重建。结果 移植后患者的临床症状完全缓解 ,狼疮相关抗体全部转阴 ,移植后患者的免疫功能均明显降低 ,约半年后恢复正常 ,但不伴有临床症状的复发。结论 免疫清除性化疗结合自体外周血造血干细胞移对难治性SLE有明显的疗效 ,尤其适用对各种药物治疗无效者 ,治疗是安全的 。 Objective To study the clinical effect of immunoablative chemotherapy with autologous peripheral blood stem cell rescule in patients with severe systemic lupus erythematosus (SLE).Methods Four severe SLE were chosen. Peripheral blood stem cell (PBSCs) were mobilized with CTX and granulocyte colony-stimulating factor (G CSF). PBSCs were reinfused after conditioned by CTX (50mg/kg every day for 3 days) + Antithymocyte globulin (5mg/kg every day for 3 days). Both clinical manifestations and lupus -correlated antigens were compared before and after transplantation. The reconstrution of immune function were observed.Results After transplantation the patients received clinical remission and immunologic abnormality returned to normal. Immune function decreased remarkably after the transplantation and resumed to normal about 6 months after the transplantation.Conclusion APBSCT is effective and safety for severe SLE. It is required to follow-up for evaluation long-term effect.. \[
出处 《临床内科杂志》 CAS 北大核心 2003年第3期127-129,共3页 Journal of Clinical Internal Medicine
关键词 造血干细胞移植 系统性红斑狼疮/治疗 Haematopoietic stem cell transplantation Systemic lupus erythematosus/therapy
  • 相关文献

参考文献8

  • 1[1]Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI:a disease activity index for lupus patients.Arthritis Rheum,1992,35:630-640.
  • 2[2]Baldwin JL,Storb R,Thamas ED,et al.Bone marrow transplantation in patients with gold-induced marrow aplasa.Arthritis Rheum,1977,20:1043-1048.
  • 3[3]Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease:a consensus report written on behalf of the European league against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant,1997,19: 643-645.
  • 4[4]Hayag MV,Cohen JA,Kerdel JA,et al.Immunoablative high-dose cyclophosphamide without stem cell rescule in a patient with pemphigus vulgaris.J Am Acad Dermatol.2000,43:1065.
  • 5[5]Euler HH,Marmont AM,Bacigalupo A,et al.Early recurrence or persistence of autoimmune disease after unmanipulated autologous stem cell transplantation.Blood,1996,88: 3621.
  • 6[6]Rosen O,Thiel A,Massenkeil G,et al.Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.Arthritis Res.2000,2:327-336.
  • 7[7]Fassas A,Anagnostostopoulos A,Kazis A,et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant, 1997, 20: 631-638.
  • 8[8]Tynadall A, Fassas A, Passweg J, et al. Autologous hemopoietic stem cell transplants for autoimmune disease: feasibility and transplant relate mortality. Bone Marrow Transplant.1999,24:729-34.

同被引文献18

  • 1马春会,朱康儿.造血干细胞移植治疗重症自身免疫性疾病[J].临床荟萃,2004,19(15):898-900. 被引量:2
  • 2吴东海,马丽.系统性红斑狼疮的诊断和治疗进展(上)[J].中华医学信息导报,2004,19(3):20-20. 被引量:2
  • 3李建华,曾抗,周再高,黄良,孙竞,彭学标,孙乐栋,徐丹,刁友涛,孟凡义.自体造血干细胞移植对SLE患者生活质量的影响[J].中国皮肤性病学杂志,2006,20(2):84-85. 被引量:4
  • 4Tyndall A, Gratwohl A. Blood and marrow stem cell transplantation in auto-immune disease:a consensus report written on behalf of the European League against Rheumatism ( EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) [ J]. Bone Marrow Transplant, 1997,19:643 -645.
  • 5Hahn BH. The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus[ J].J Rheumatol Suppl, 1997,48: 89-93.
  • 6Traynor AE, Barr WG, Rosa RM, et al. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients [ J ]. Arthritis rheum,2002,46: 2917 -2923.
  • 7Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease [J]. Nat Rev Immunol,2001,1(2) :147-153.
  • 8Jayne D, Tyndall A. Autologous stem cell transplantation for systemic lupus erythematosus [J]. Lupus, 2004, 13 ( 5 ) : 359- 365.
  • 9Jayne D, Passweg J, Marmont A, et al. Autologous stem cell transplantation for systemic lupus erythematosus[J]. Lupus, 2004,13 (3):168-176.
  • 10Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus[J]. JAMA, 2006,295 (5) : 527-535.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部